However, all these older drugs are facing declining sales due to biosimilar or branded competition, which is being somewhat offset by its blockbuster growth drugs like Prolia and Xgeva.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the ...

Dr. Reddy's Laboratories (NYSE:RDY) has denied reports that the company will be laying off its workforce to cut labor costs ...

Hero MotoCorp Ltd has announced that production will be temporarily paused from April 17 to 19, 2025, at four of our ...

In a strategic move to optimize its manufacturing capacities, Renaissance Global Ltd (RGL), a leading player in the fine jewelry export segment, has decided to discontinue manufacturing operations at ...

a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain ...

Mumbai Sessions Court Denies Anticipatory Bail To Colaba Club Finance Head, Auditor In ₹11 Crore Misappropriation Case 17 April 2025, 07:16 AM Mumbai News: ACB Books 59-Year-Old GST Officer For ...

Permian Resources Corporation, an independent oil and natural gas company, focuses on the development of crude oil and associated liquids-rich natural gas reserves in the United States. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...